The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects (PIMS)
The Use of the Prevena Incision Management System on Closed Recipient Site Incisions in Renal Transplant Subjects
Sponsor: KCI USA, Inc
Terminated
Enrollment Difficulties
Other terminated trials from KCI USA, Inc
- Abdominoplasty · Phase NA · Jul 2017
- Diabetic Foot Ulcers · Phase NA · Nov 2010
- Diabetic Amputation Foot Wound · Phase NA · Apr 2008
More terminations from KCI USA, Inc
This NA trial investigates Surgical Site Reaction and is currently terminated or withdrawn. KCI USA, Inc leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Nov 2024 — Sep 2025 [monthly]
Terminated NA
-
Sep 2024 — Nov 2024 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Sep 2022 — Dec 2022 [monthly]
Terminated NA
-
Jan 2021 — Sep 2022 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Aug 2017 — Jun 2018 [monthly]
Terminated NA
Phase: PHASE3 → NA
-
Feb 2017 — Aug 2017 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- KCI USA, Inc
For direct contact, visit the study record on ClinicalTrials.gov .